Cyclothymic disorder is the bipolar spectrum's chronic, sub-threshold form. The diagnostic criteria require sub-threshold hypomanic and depressive symptoms for at least 2 years (1 year in children/adolescents), with the symptoms present at least half the time and never fully meeting criteria for a major depressive or hypomanic episode.
The phenotype is best understood as a temperament rather than a series of episodes. Patients oscillate between periods of mild mood elevation (slightly higher energy, slightly less sleep need, slightly more activity, slightly more impulsivity) and periods of mild depression (mildly low mood, mild anhedonia, mild fatigue). Neither pole reaches the intensity of bipolar episodes. The pattern is the disease.
The clinical impact is substantial despite the relative mildness. Cyclothymic patients often have chronic relationship instability, employment instability, financial fluctuations, and identity instability — they cannot count on their own internal weather. Decisions made during sub-threshold elevation are regretted during sub-threshold depression. The sense of an unchanging self is hard to maintain.
The conversion risk: 15-50% of cyclothymic patients eventually progress to full bipolar I or II disorder. The progression often happens during major life stressors, substance use periods, or after stimulant or antidepressant treatment without mood stabilizer cover. Early recognition and intervention may reduce conversion risk, though the evidence is limited.
Treatment is challenging because the symptoms don't reach the threshold that drives intensive pharmacotherapy. Many patients describe themselves as "moody" and don't seek treatment until functional consequences accumulate. When treatment is offered: mood stabilizers (lithium, lamotrigine, valproate) at lower doses than for bipolar I; psychotherapy with attention to mood patterns, decision-making, and life structure; substance use avoidance (alcohol, stimulants particularly destabilizing); regular sleep schedule and circadian stability.
A key clinical consideration: avoid antidepressant monotherapy. Cyclothymic patients may present with the depressive pole, get diagnosed with unipolar depression, and be started on SSRIs alone. This can trigger frank hypomanic or manic episodes, converting cyclothymia to bipolar II or I. Screening for the broader pattern before treatment is essential.
When you encounter a patient describing chronic moodiness, especially with a family history of bipolar disorder, ask about the longitudinal pattern. Cyclothymia is real, undertreated, and a potential precursor to more severe illness. Recognition and management early may alter trajectory.